Concepedia

Publication | Closed Access

Molecular correlates differentiate response to atezolizumab (atezo) + bevacizumab (bev) vs sunitinib (sun): Results from a phase III study (IMmotion151) in untreated metastatic renal cell carcinoma (mRCC)

DOI

72

Citations

0

References

2018

Year

Brian I. Rini, Mahrukh Huseni, Michael B. Atkins, David F. McDermott, T.B. Powles, Bernard Escudier, Romain Banchereau, L.-F. Liu, Ning Leng, Junjie Fan,
Annals of Oncology

No additional data available for this publication yet. Check back later!